Latest article
Mankind Pharma launches drug to deal with diabetes, coronary heart failure and CKD
Mankind Pharma has launched Justoza, a brand of dapagliflozin marketed by Mankind for the treatment of diabetes, heart failure and chronic kidney disease. ...
Natural Important Oils Market to Witness a Pronounce Development Throughout 2027 – SoccerNurds
Fort Collins, Colorado: The report with the title Organic Essential Oils Marketis one of the most comprehensive and important additions...
Novo Nordisk presents trial outcomes of Xultophy for sort 2 diabetes
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...